FDA Will Allow 10 Minor ANDA Corrections Before Refusing To Receive
This article was originally published in The Tan Sheet
Executive Summary
Generic Drug User Fee Act refuse-to-receive draft guidance says FDA will allow sponsors to make a few small fixes to applications, but the agency will not accept any ANDAs with big problems, which will trigger automatic refuse-to-file actions.